Reports
Sale
Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share, Size, Analysis, Forecast: By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Others; By Route of Administration: Oral, Parenteral; By Distribution Channels: Hospital Pharmacy, Retail Pharmacy, Others; Regional Analysis; Competitive Landscape; 2024-2032
Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Outlook
The global non-steroidal anti-inflammatory drugs (NSAIDs) market attained a value of USD 20.59 billion in 2023. The market is further expected to grow at a CAGR of 5.40% between 2024 and 2032 to reach a value of USD 28.23 billion by 2032.
Key Trends in the Market
Non-steroidal anti-inflammatory drugs (NSAIDs) are a type of medication which are used to reduce pain, fever, and inflammation, and are also helpful in preventing blood clots. They act as an enzyme inhibitor and are used to treat various discomforts such as headache, back ache, fever, dental pain, menstrual cramp, and arthritis, among others. Ibuprofen, Naproxen, and Celecoxib are some common examples of NSAIDs.
- The global non-steroidal anti-inflammatory drugs (NSAIDs) market growth is being driven by heightening cases of conditions such as arthritis, viral, and inflammation. Increasing prevalence of migraine and body pain due to lifestyle-related issues and hectic lifestyles are further propelling the demand for NSAIDs.
- Increasing health consciousness, accessibility of healthcare services, and rapid advancements in the healthcare infrastructure are escalating the number of NSAIDs prescriptions. A key trend in the market is the availability of several NSAIDs over-the-counter, which is increasing their purchase directly by consumers.
- Rising investments to bolster the research and development infrastructure across the pharmaceutical sector are expected to fuel the development of non-steroidal anti-inflammatory drugs (NSAIDs) in the forecast period. In addition, the robust product innovations are further likely to augment the non-steroidal anti-inflammatory drugs (NSAIDs) market dynamics in the coming years.
Market Analysis
Based on disease indication, the market can be segmented into arthritis, migraine, and ophthalmic diseases, among others. On the basis of route of administration, the market can be classified into oral and parenteral. Based on distribution channels, the market can be categorised into hospital pharmacy, retail pharmacy, and online pharmacy, among others. The regional markets can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global non-steroidal anti-inflammatory drugs (NSAIDs) market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
- Assertio Holdings, Inc.
- Bayer AG
- Amgen Inc
- Lion Corporation
- Dr. Reddy’s Laboratories Ltd.
- Novartis AG
- Others
Market Share by Disease Indication
The ophthalmic diseases segment, based on disease indication, holds a significant share in the non-steroidal anti-inflammatory drugs (NSAIDs) market. The increasing prevalence of refractive errors, cataract, and macular degeneration, among the geriatric population is a major cause of the segment’s growth. Additionally, the lack of proper nutrition caused by the sedentary lifestyles led by the working population is further escalating ophthalmic disorders.
Meanwhile, the arthritis segment is expected to witness a steady growth in the forecast period due to the growing cases of autoimmune inflammatory arthritis. Over the forecast period, the increasing health concerns among the population is expected to propel the demand for the NSAIDs, providing impetus to the market for non-steroidal anti-inflammatory drugs (NSAIDs).
Market Share by Distribution Channels
The retail pharmacy segment, based on distribution channel, holds a significant share in the non-steroidal anti-inflammatory drugs (NSAIDs) market. As NSAIDs are commonly purchased directly by consumers in over-the-counter format as well as on a prescription basis, the retail pharmacy distribution channel occupies a sizable share of the market. The increasing sale of diclofenac, aspirin, and celecoxib, among others is fuelling the growth of the retail pharmacy segment.
The increasing prevalence of rheumatoid arthritis and rising investments towards healthcare development across the urban areas of emerging economies are bolstering the sale of NSAIDs in retail pharmacies. Meanwhile, the online segment is expected to witness a decent growth in the forecast period owing to the emergence of mobile pharma applications. Moreover, the rapid digitalisation across the healthcare sector is further likely to escalate the sales of NSAIDs in online pharmacies in the coming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
Assertio Holdings, Inc. is one of the leading pharmaceutical companies based in United States. It was founded in the year 1995 and is currently headquartered in Illinois. Assertio Holdings, Inc. majorly focusses on medications related to neurology, inflammation, and pain, among other chronic disorders. It provides nasal sprays, tablets, capsules, and suppositories, among other products.
Bayer AG is a prominent life science company which is based in Leverkusen, Germany. The company was founded in the year 1863 and is currently offering innovative products in the field of healthcare and agriculture. Bayer AG also produces seeds and biotechnological products to cater to the demands of various end use industries.
Amgen Inc: is a renowned biotechnology company which is headquartered in California in the United States. The company was founded in the year 1980 and is involved in manufacturing and innovating various scientific and medical products. Amgen Inc operates in around 100 countries. Some examples of the products innovated by this company include Aranesp and Avsola.
Other market players include Lion Corporation, Dr. Reddy’s Laboratories Ltd., and Novartis AG, among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Disease Indication |
|
| Breakup by Route of Administration |
|
| Breakup by Distribution Channels |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis
8.1 Key Industry Highlights
8.2 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Historical Market (2018-2023)
8.3 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2024-2032)
8.4 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Disease Indication
8.4.1 Arthritis
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Migraine
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Ophthalmic Diseases
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.4.4 Others
8.5 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Route of Administration
8.5.1 Oral
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Parenteral
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.6 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Distribution Channels
8.6.1 Hospital Pharmacy
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Retail Pharmacy
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Online Pharmacy
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2023)
8.6.3.3 Forecast Trend (2024-2032)
8.6.4 Others
8.7 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2023)
8.7.1.3 Forecast Trend (2024-2032)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2023)
8.7.2.3 Forecast Trend (2024-2032)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2023)
8.7.3.3 Forecast Trend (2024-2032)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2023)
8.7.4.3 Forecast Trend (2024-2032)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2023)
8.7.5.3 Forecast Trend (2024-2032)
9 North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2023)
9.1.3 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2023)
9.2.3 Forecast Trend (2024-2032)
10 Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2023)
10.1.3 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2023)
10.2.3 Forecast Trend (2024-2032)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2023)
10.3.3 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2023)
10.4.3 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2023)
11.1.3 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2023)
11.2.3 Forecast Trend (2024-2032)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2023)
11.3.3 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2023)
11.4.3 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2023)
11.5.3 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2023)
12.1.3 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2023)
12.2.3 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2023)
12.3.3 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2023)
13.1.3 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2023)
13.2.3 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2023)
13.3.3 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2023)
13.4.3 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Assertio Holdings, Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Bayer AG
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Amgen Inc
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Lion Corporation
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Dr. Reddy’s Laboratories Ltd.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Novartis AG
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market: Key Industry Highlights, 2018 and 2032
2. Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Historical Market: Breakup by Disease Indication (USD Million), 2018-2023
3. Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast: Breakup by Disease Indication (USD Million), 2024-2032
4. Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Historical Market: Breakup by Route of Administration (USD Million), 2018-2023
5. Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast: Breakup by Route of Administration (USD Million), 2024-2032
6. Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Historical Market: Breakup by Distribution Channel (USD Million), 2018-2023
7. Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast: Breakup by Distribution Channel (USD Million), 2024-2032
8. Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Historical Market: Breakup by Region (USD Million), 2018-2023
9. Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast: Breakup by Region (USD Million), 2024-2032
10. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historical Market: Breakup by Country (USD Million), 2018-2023
11. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Historical Market: Breakup by Country (USD Million), 2018-2023
13. Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Historical Market: Breakup by Country (USD Million), 2018-2023
15. Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historical Market: Breakup by Country (USD Million), 2018-2023
17. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Middle East and Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Historical Market: Breakup by Country (USD Million), 2018-2023
19. Middle East and Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast: Breakup by Country (USD Million), 2024-2032
20. Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Structure
Key Questions Answered in the Report
The global market for non-steroidal anti-inflammatory drugs (NSAIDs) attained a value of USD 20.59 billion in 2023.
The market is estimated to grow at a CAGR of 5.40% in the forecast period of between 2024 and 2032.
The non-steroidal anti-inflammatory drugs (NSAIDs) market is projected to reach a value of USD 28.23 billion by 2032.
The increasing prevalence of lifestyle related issues such as migraine, body pain, and fever, and increasing cases of arthritis and ophthalmic disorders, and are the major drivers of the market.
The key trends in the market include the rising geriatric population, increasing consumer awareness, availability of NSAIDs as over-the-counter medication, and growing expansion of the research and development infrastructure which is heightening the product innovations.
Arthritis, migraine, and ophthalmic diseases, among others are the different segments based on disease indication.
Hospital pharmacy, retail pharmacy, and online pharmacy, among others, are the major distribution channels included in the market.
Ibuprofen, naproxen, diclofenac, celecoxib, and mefenamic acid, among others, are the examples of non-steroidal anti-inflammatory drugs.
Diclofenac is considered as one of the strongest non-steroidal anti-inflammatory drugs.
Assertio Holdings, Inc., Bayer AG, Amgen Inc, Lion Corporation, Dr. Reddy’s Laboratories Ltd., and Novartis AG, among others, are the key market players, according to the report.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3199
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4199
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5199
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER